A Targeted Library of Small-Molecule, Tyrosine, and Dual-Specificity Phosphatase Inhibitors Derived from a Rational Core Design and Random Side Chain Variation
- 1 December 1997
- journal article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 36 (50), 15965-15974
- https://doi.org/10.1021/bi971338h
Abstract
Tyrosine phosphatases (PTPases) dephosphorylate phosphotyrosines while dual-specificity phosphatases (DSPases) dephosphorylate contiguous and semicontiguous phosphothreonine and phosphotyrosine on cyclin dependent kinases and mitogen-activated protein kinases. Consequently, PTPases and DSPases have a central role controlling signal transduction and cell cycle progression. Currently, there are few readily available potent inhibitors of PTPases or DSPases other than vanadate. Using a pharmacophore modeled on natural product inhibitors of phosphothreonine phosphatases, we generated a refined library of novel, phosphate-free, small-molecule compounds synthesized by a parallel, solid-phase combinatorial-based approach. Among the initial 18 members of this targeted diversity library, we identified several inhibitors of DSPases: Cdc25A, -B, and -C and the PTPase PTP1B. These compounds at 100 μM did not significantly inhibit the protein serine/threonine phosphatases PP1 and PP2A. Kinetic studies with two members of this library indicated competitive inhibition for Cdc25 DSPases and noncompetitive inhibition for PTP1B. Compound AC-αα69 had a Ki of approximately 10 μM for recombinant human Cdc25A, -B, and -C, and a Ki of 0.85 μM for the PTP1B. The marked differences in Cdc25 inhibition as compared to PTP1B inhibition seen with relatively modest chemical modifications in the modular side chains demonstrate the structurally demanding nature of the DSPase catalytic site distinct from the PTPase catalytic site. These results represent the first fundamental advance toward a readily modifiable pharmacophore for synthetic PTPase and DSPase inhibitors and illustrate the significant potential of a combinatorial-based strategy that supplements the rational design of a core structure by a randomized variation of peripheral substituents.Keywords
This publication has 12 references indexed in Scilit:
- Asymmetric synthesis of RK-682 and its analogs, and evaluation of their protein phosphatase inhibitory activitiesTetrahedron Letters, 1996
- Kinetic Analysis of the Catalytic Domain of Human Cdc25BPublished by Elsevier BV ,1996
- Identification of an essential acidic residue in Cdc25 protein phosphatase and a general three‐dimensional model for a core region in protein phosphatasesProtein Science, 1996
- Synthesis and Protein Tyrosine Phosphatase Inhibitory Activity of Dephostatin Analogs.The Journal of Antibiotics, 1995
- Coupling N-Methylated Amino Acids Using PyBroP and PyCloP Halogenophosphonium Salts: Mechanism and Fields of ApplicationThe Journal of Organic Chemistry, 1994
- The conserved acid binding domain model of inhibitors of protein phosphatases 1 and 2A: Molecular modelling aspects.Bioorganic & Medicinal Chemistry Letters, 1993
- Higher eucaryotic cdc25 proteins are structurally related to phosphoseryl/threonyl protein phosphatasesBiology of the Cell, 1992
- Tautomycin from the bacterium Streptomyces verticillatusFEBS Letters, 1990
- Inhibition of protein phosphatases by microcystis and nodularin associated with hepatotoxicityZeitschrift für Krebsforschung und Klinische Onkologie, 1990
- Diphenylphosphoryl azide. New convenient reagent for a modified Curtius reaction and for peptide synthesisJournal of the American Chemical Society, 1972